5-Minute Clinical Consult

Anemia, Autoimmune Hemolytic

Anemia, Autoimmune Hemolytic was found in 5-Minute Clinical Consult which helps you diagnose, treat, and follow up on over 900 medical conditions seen in everyday practice.

To view this entire topic, please or purchase a subscription.

Explore 5-Minute Clinical Consult - view these FREE monographs:

5-Minute Clinical Consult

-- The first section of this topic is shown below --

Basics

Description

  • Increased destruction of RBCs in the presence of anti-RBC autoantibodies (1)
  • 3 main types defined by maximal binding temperature of the autoantibodies (1):
    • Warm-reacting [at 37°C or 98.6°F] IgG antibody: Seen in 80–90% of cases
    • Cold-reacting [<37°C or 98.6°F] IgM or IgG antibody
    • Mixed type: Both warm-reacting IgG and cold-reacting C3 antibodies
  • Drug-induced: Mostly warm-reacting IgG antibodies
  • System(s) affected: Hematopoietic; Lymphatic; Immunologic

Epidemiology


Incidence
  • Predominant age: Adults 40–50 years (2)
  • Predominant sex: Female > Male
  • Annual incidence of 1–3/100,000 individuals (1)
  • Cold agglutinin: Primarily affects young patients (2)

Risk Factors

  • Malignancy
  • Autoimmune disorders
  • Infection
  • Medications
  • Prior blood transfusion
  • Prior hematopoietic cell transplant

Genetics
No known genetic or familial hereditary component (2)

Pathophysiology

  • Warm autoimmune hemolytic anemia (AIHA): IgG attaches to RBCs, which are then ingested by splenic macrophages.
  • Cold AIHA:
    • IgM binding to RBC surfaces activates C3b-mediated phagocytosis by liver Kupffer cells (2).
    • Rare mechanism in setting of low IgM levels: Membrane attack complex insertion causes intravascular hemolysis (2).
  • Mixed-antibody AIHA: Warm IgG and cold C3 involved (2)
  • Drug-induced:
    • Hapten-induced: Drug attaches to RBC to induce IgG production.
    • Immune complex: Drug–IgM immune complex binds RBC to activate complement.
    • Autoantibody: Drug induces production of anti-RBC IgG.

Etiology

  • Autoantibody most common cause (1):
    • Warm antibody (48–70% of cases):
      • Primary cause: Idiopathic (most common cause)
      • Secondary causes:
        • Lymphoproliferative disorders: Chronic lymphocytic leukemia, Hodgkin lymphoma, non-Hodgkin lymphoma
        • Autoimmune disorders: Systemic lupus erythematosus (SLE)
        • Viral infections: Especially common in children
        • Chronic inflammatory disorders: Crohn disease, ulcerative colitis
    • Cold antibody:
      • Primary: Less common than secondary causes (3):
        • Defined as patient with IgM monoclonal gammopathy of undetermined significance (MGUS) or lymphoma without overt clinical significance with bone marrow infiltration
        • Usually very mild anemia
      • Cold agglutinin syndrome (CAS, 16–32% of cases):
        • Acute: Infections (mycoplasma, mononucleosis, viral)
        • Chronic: Lymphoproliferative disorders (lymphoma) (2)
        • Paroxysmal cold hemoglobinuria
    • Alloantibody (2):
      • Posttransplant
      • Pregnancy
      • Posttransfusion
  • Mixed type:
    • Idiopathic
    • Secondary to lymphoproliferative or autoimmune disorders
  • Drug-induced (2,4):
    • Most common drug: Fludarabine (autoantibody-induced)
    • Penicillin: Hapten-induced
    • Quinine: Immune complex
    • α-methyldopa: Autoantibody-induced
    • Also seen with cefotetan, ceftriaxone, alemtuzumab, mycophenolate, purine analogs, alkylating agents

Commonly Associated Conditions

  • Evans syndrome (AIHA and idiopathic thrombocytopenic purpura)
  • SLE
  • Chronic lymphocytic leukemia (CLL): AIHA is the most common autoimmune condition associated with CLL; it occurs in 5–37% of patients with CLL (5).
  • Diffuse lymphomas

-- To view the remaining sections of this topic, please or purchase a subscription --